156 related articles for article (PubMed ID: 33468827)
21. Hyperammonemia with impaired consciousness caused by continuous 5-fluorouracil infusion for colorectal cancer: A case report.
Nakamura T; Shibata S; Miyatani Y; Matsubara H
Int J Clin Pharmacol Ther; 2020 Dec; 58(12):727-731. PubMed ID: 32909537
[TBL] [Abstract][Full Text] [Related]
22. [A Case Altered Consciousness Due to 5-Fluorouracil-Induced Hyperammonemia in a Patient with Recurrent Colorectal Cancer].
Sawazaki S; Numata M; Ju M; Morita J; Komori K; Maezawa Y; Amano S; Aoyama T; Tamagawa H; Sato T; Oshima T; Mushiake H; Yukawa N; Masuda M; Rino Y
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1632-1634. PubMed ID: 31631158
[TBL] [Abstract][Full Text] [Related]
23. [Hyperammonemic encephalopathy after treatment with modified FOLFOX6 regimen for recurrent gastric cancer:a case report].
Kuwabara S; Murakawa K; Kumagai K; Takeuchi Y; Wada H; Ichinokawa M; Matsumoto J; Ono K; Hirano S
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(1):72-78. PubMed ID: 35022374
[TBL] [Abstract][Full Text] [Related]
24. [A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].
Teraishi F; Suzuki T; Nakamoto M; Chikuba A; Nezu M; Shimamura H; Watanabe T; Matsuda T; Takiue T; Chikuba H
Gan To Kagaku Ryoho; 2009 May; 36(5):867-9. PubMed ID: 19461197
[TBL] [Abstract][Full Text] [Related]
25. [A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
Okamura T; Kawachi Y; Nikkuni K; Nishimura A; Makino S; Kawahara M; Kitami C; Hashimoto Y
Gan To Kagaku Ryoho; 2013 May; 40(5):671-3. PubMed ID: 23863598
[TBL] [Abstract][Full Text] [Related]
26. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
Di Federico A; Nuvola G; Sisi M; Lenzi B; Nobili E; Campana D
Anticancer Drugs; 2020 Nov; 31(10):1103-1105. PubMed ID: 32826413
[TBL] [Abstract][Full Text] [Related]
27. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
28. A case of advanced rectal cancer with rectovesical and ileal fistulae that developed hyperammonemic encephalopathy.
Maruyama M; Miyasaka Y; Takano A; Inoue M; Furuya K; Sugai H; Hada M; Nakagomi H
Surg Case Rep; 2015 Dec; 1():88. PubMed ID: 26435908
[TBL] [Abstract][Full Text] [Related]
29. [Case of Hyperammonemia Induced by High-Dose Fluorouracil].
Hagiwara A; Abe M; Mafune K; Saito M; Kusakabe A
Gan To Kagaku Ryoho; 2019 May; 46(Suppl 1):147-149. PubMed ID: 31189842
[TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report.
Ogata T; Satake H; Ogata M; Hatachi Y; Yasui H
Case Rep Oncol; 2017; 10(3):885-889. PubMed ID: 29118705
[TBL] [Abstract][Full Text] [Related]
31. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
Lee NR; Yhim HY; Yim CY; Kwak JY; Song EK
Ann Pharmacother; 2011 Oct; 45(10):e56. PubMed ID: 21954449
[TBL] [Abstract][Full Text] [Related]
32. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
33. Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.
Mitani S; Kadowaki S; Komori A; Sugiyama K; Narita Y; Taniguchi H; Ura T; Ando M; Sato Y; Yamaura H; Inaba Y; Ishihara M; Tanaka T; Tajika M; Muro K
Medicine (Baltimore); 2017 Jun; 96(22):e6874. PubMed ID: 28562536
[TBL] [Abstract][Full Text] [Related]
34. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
Nagasaka T; Mishima H; Sawaki A; Shimokawa M; Inukai M; Shinozaki K; Tanioka H; Nasu J; Nishina T; Hazama S; Okajima M; Yamaguchi Y
BMJ Open; 2016 Jun; 6(6):e011454. PubMed ID: 27256093
[TBL] [Abstract][Full Text] [Related]
35. [Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].
Esaki M; Ishii K; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ito T; Nomura S
Rinsho Ketsueki; 2016 Jul; 57(7):854-8. PubMed ID: 27498728
[TBL] [Abstract][Full Text] [Related]
36. [Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
Shioiri M; Hasegawa M; Tanaka H; Toura I; Kudo S; Sato K; Inoue K; Nakanishi T; Nishiyama S; Takebe S; Ogino Y; Ohsaki S; Nagashima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2198-200. PubMed ID: 23268022
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
[TBL] [Abstract][Full Text] [Related]
38. [Two Cases of Rectal Cancer Resected Curatively after Chemotherapy with CapeOX plus Bmab].
Chiku T; Sano W; Hashiba T; Togawa Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1647-9. PubMed ID: 26805125
[TBL] [Abstract][Full Text] [Related]
39. [A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
Tago T; Suzuki K; Nishida K; Maruyama T; Shimazaki J; Shimoda M; Suzuki S; Kou K; Morishita Y
Gan To Kagaku Ryoho; 2018 May; 45(5):871-874. PubMed ID: 30026455
[TBL] [Abstract][Full Text] [Related]
40. [A case of advanced rectal cancer with lung and bone metastasis that was successfully treated with mFOLFOX6+bevacizumab].
Masuda T; Uetake H; Yamauchi S; Okazaki S; Matsuyama T; Ishiguro M; Ishikawa T; Kobayashi H; Iida S; Higuchi T; Sugihara K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2264-6. PubMed ID: 23268044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
